Mode
Text Size
Log in / Sign up
N/A N=33 Prevention

Diabetes Prevention Program in Youth

Pre Diabetes

Enrolled (actual)
33
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Change From Baseline Hemoglobin A1c — -0.5 A1c percentage points

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Insulin Superheroes Club Curriculum (Behavioral)
Age
Pediatric · 7+ yrs
Sex
All
Sponsor
University of Tennessee
Primary completion
Nov 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Change From Baseline Hemoglobin A1c
-0.5
SECONDARY
Change From Baseline Body Mass Index Z-score
SECONDARY
Change From Baseline Waist Circumference Z-score
SECONDARY
Change From Baseline Systolic Blood Pressure Z-score
SECONDARY
Change From Baseline Diastolic Blood Pressure Z-score
SECONDARY
Change From Baseline Percent Body Fat
SECONDARY
Change From Baseline Total Cholesterol
SECONDARY
Change From Baseline LDL Cholesterol
SECONDARY
Change From Baseline HDL Cholesterol
SECONDARY
Change From Baseline Non-HDL Cholesterol
SECONDARY
Change From Baseline Triglycerides
SECONDARY
Change From Baseline Six Minute Walk Test Distance
SECONDARY
Change From Baseline Right Handgrip Strength
SECONDARY
Change From Baseline Left Handgrip Strength
SECONDARY
Change From Baseline Combined Handgrip Strength
SECONDARY
Change From Baseline Sit-and-reach Lower Body Flexibility
SECONDARY
Change From Baseline Shuttle Run Speed

Summary

The purpose of this study is to test the effectiveness of an out-of-school diabetes prevention program for youth (ages 7-15) with a family history of pre-diabetes or type 2 diabetes.

Eligibility Criteria

Inclusion criteria

  • Between 7-15 years old
  • Parent or grandparent with pre/type II Diabetes
  • Able to participate in physical activity
  • Parent or caregiver participation

Exclusion criteria

  • Pregnant females
  • Those with significant physical or mental health illness that would hinder study participation
  • Medications that would interfere with testing results
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03042936). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search